With $58M in hand, the start­up team at Pan­dion sets their sights on a next-gen ap­proach to im­munol­o­gy

An­tho­ny Coyle start­ed Pfiz­er’s Cen­ters for Ther­a­peu­tic In­no­va­tion with an eye to chang­ing the way the phar­ma gi­ant went about the busi­ness of drug dis­cov­ery …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER